We are live on ! Find out more
ACET icon

Adicet Bio
ACET

76 hedge funds and large institutions have $68.3M invested in Adicet Bio in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more capital invested

Capital invested by funds: $48.9M → $68.3M (+$19.5M)

16% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 25

0.06% more ownership

Funds ownership: 5.18% → 5.24% (+0.06%)

8% less funds holding

Funds holding: 83 → 76 (-7)

43% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 14

96% less call options, than puts

Call options by funds: $4K | Put options by funds: $90K

Holders
76
Holders Change
-7
Holders Change %
-8.43%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
29
Reduced
25
Closed
14
Calls
$4K
Puts
$90K
Net Calls
-$86K
Net Calls Change
-$25K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$2.4M
2
Millennium Management
Millennium Management
New York
+$583K
3
SSA
Schonfeld Strategic Advisors
New York
+$273K
4
Two Sigma Investments
Two Sigma Investments
New York
+$185K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$182K

Top Sellers

Rank Fund Capital Flow
1
DCM
DAFNA Capital Management
California
-$1.09M
2
TCM
Tang Capital Management
California
-$477K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$457K
4
BCM
Bridgeway Capital Management
Texas
-$265K
5
Marshall Wace
Marshall Wace
United Kingdom
-$209K
Name Holding Trade Value Shares
Change 		Change in
Stake
TIM
76
Thompson Investment Management
Wisconsin
$151 – – –
Zurich Cantonal Bank
77
Zurich Cantonal Bank
Switzerland
$4 – – –
DCM
78
DAFNA Capital Management
California
– -$1.09M -49,816 Closed
Jacobs Levy Equity Management
79
Jacobs Levy Equity Management
New Jersey
– -$457K -20,850 Closed
Marshall Wace
80
Marshall Wace
United Kingdom
– -$209K -9,532 Closed
AI
81
Acuitas Investments
Washington
– -$187K -8,549 Closed
AQR Capital Management
82
AQR Capital Management
Connecticut
– -$103K -4,689 Closed
MAM
83
Marquette Asset Management
Minnesota
– -$38.6K -1,759 Closed
American Century Companies
84
American Century Companies
Missouri
– -$29.9K -1,362 Closed
Balyasny Asset Management
85
Balyasny Asset Management
Illinois
– -$17.2K -784 Closed
Comerica Bank
86
Comerica Bank
Texas
– -$1.71K -78 Closed
CUAMC
87
China Universal Asset Management Company
China
– -$1.51K -69 Closed
Russell Investments Group
88
Russell Investments Group
United Kingdom
– -$960 -44 Closed
Nisa Investment Advisors
89
Nisa Investment Advisors
Missouri
– -$121 -6 Closed
S
90
SignatureFD
Georgia
– -$22 -1 Closed
1 2 3
4

ACET Hedge Fund Activity: Q4 2023 in Review

76 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q4 2023, worth a combined $68.3M — up 40% from $48.9M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of ACET and 8 opened new positions — a net loss of 6 holders — while 25 trimmed existing stakes and 29 added.

The largest buyer was Morgan Stanley, adding an estimated $2.4M. The largest seller was DAFNA Capital Management, exiting entirely with an estimated $1.09M sold.

  • 76 institutional investors held Adicet Bio (ACET) as of Q4 2023, down from 83 in Q3 2023.
  • Funds reported $68.3M of Adicet Bio stock for Q4 2023, up 40% quarter-over-quarter.
  • 8 funds opened new Adicet Bio positions in Q4 2023 and 14 closed out, a net change of -6 holders.
  • The largest Adicet Bio buyer in Q4 2023 was Morgan Stanley, an estimated $2.4M added.
  • The largest Adicet Bio seller in Q4 2023 was DAFNA Capital Management, an estimated $1.09M sold.

Based on aggregated 13F filings for Q4 2023.